Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$98.2M
+15.2% from 2023
Prescriptions
3,428
$28,651.69 per claim
Patients
1,103
963 prescribers
Total spending, 2024
$98.2M
$89,046.23 per patient
Medicare prescription drug plans paid $98.2M for Xpovio in 2024, for 3,428 prescriptions and refills to 1,103 patients (up 15.2% from 2023). The average cost per claim was $28,651.69.
New York had the highest Medicare cost for Xpovio in 2024: $8.2M for 283 claims, followed by California ($7.3M).
Rajesh Behl, hematology in Berkeley, CA, had the highest Medicare cost for Xpovio in 2024: 43 claims costing $1.3M.
Xpovio is made by Karyopharm Therapeutics Inc. (KPTI), listed in the Medicare spending data as Karyopharm Ther.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rajesh Behl Berkeley, CA | Hematology | 43 | Under 11 | $1.3M |
| Mojtaba Akhtari Omaha, NE | Hematology-Oncology | 31 | Under 11 | $950K |
| Matthew J Butler |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,050 | 3,583 | 1,218 | $86.7M |
| 2023 | 973 | 3,209 | 1,112 | $85.3M |
| 2024 | 963 | 3,428 | 1,103 | $98.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 28 |
| Under 11 |
| $899K |
| Adam F Binder Philadelphia, PA | Medical Oncology | 23 | Under 11 | $697K |
| Guangzhi Qu Jackson, MS | Hematology-Oncology | 23 | Under 11 | $672K |
| Ian T Lund Buffalo, NY | Physician Assistant | 22 | Under 11 | $651K |
| William Tse Cleveland, OH | Internal Medicine | 21 | Under 11 | $642K |
| Cristina Gasparetto Durham, NC | Hematology-Oncology | 25 | Under 11 | $619K |
| Margaret McCabe Poughkeepsie, NY | Nurse Practitioner | 21 | Under 11 | $578K |
| Ami P Ndiaye Charlotte, NC | Nurse Practitioner | 18 | Under 11 | $559K |
| Shachar Peles Palm Springs, FL | Hematology-Oncology | 18 | Under 11 | $555K |
| Robert B Berryman Dallas, TX | Medical Oncology | 18 | Under 11 | $524K |
| Sumit Madan Gilbert, AZ | Medical Oncology | 17 | Under 11 | $522K |
| Douglas W Sborov Salt Lake City, UT | Hematology-Oncology | 18 | Under 11 | $484K |
| Jennifer L Holly Jackson, MS | Nurse Practitioner | 17 | Under 11 | $478K |
| Harsh Parmar Hackensack, NJ | Medical Oncology | 20 | Under 11 | $470K |
| John P Winters III Westbrook, ME | Hematology-Oncology | 15 | Under 11 | $468K |
| Jonathan L Kaufman Atlanta, GA | Hematology-Oncology | 15 | Under 11 | $456K |
| Jeremy S McDuffie Murfreesboro, TN | Hematology-Oncology | 15 | Under 11 | $456K |
| Vathveal Mathews New York, NY | Nurse Practitioner | 20 | Under 11 | $452K |
| Shannon M Higgins New York, NY | Nurse Practitioner | 14 | Under 11 | $443K |
| Kruti Patel Cincinnati, OH | Hematology-Oncology | 15 | Under 11 | $436K |
| Harshad V Amin Plantation, FL | Hematology-Oncology | 13 | Under 11 | $436K |
| Revathi Kollipara Mount Juliet, TN | Internal Medicine | 16 | Under 11 | $434K |
| Jamal G Misleh Newark, DE | Hematology-Oncology | 14 | Under 11 | $423K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Karyopharm Ther KPTI | 3,428 | $98.2M |